JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2001; 38:778-784
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, H.
Right arrow Articles by Omran, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, H.
Right arrow Articles by Omran, H.

CLINICAL STUDY: STROKE

Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance

Harald Schmidt, MDa, Giso von der Reckea, Stefan Illien, MDa, Thorsten Lewalter, MDa, Rainer Schimpf, MDa, Christian Wolpert, MDa, Harald Becher, MDa, Berndt Lüderitz, MD, FACCa and Heyder Omran, MDa

a Department of Medicine–Cardiology, University of Bonn, Bonn, Germany

Manuscript received October 5, 2000; revised manuscript received March 19, 2001, accepted June 8, 2001.

Reprint requests and correspondence: Dr. Heyder Omran, Department of Medicine–Cardiology, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany
Omran{at}uni-bonn.de

OBJECTIVES

The study was done to assess the prevalence of left atrial (LA) chamber and appendage thrombi in patients with atrial flutter (AFl) scheduled for electrophysiologic study (EPS), to evaluate the prevalence of thromboembolic complications after transesophageal echocardiographic (TEE)-guided restoration of sinus rhythm and to evaluate clinical risk factors for a thrombogenic milieu.

BACKGROUND

Recent studies showed controversial results on the prevalence of atrial thrombi and the risk of thromboembolism after restoring sinus rhythm in patients with AFl.

METHODS

Between 1995 and 1999, patients with AFl who were scheduled for EPS were included in the study. After transesophageal assessment of the left atrial appendage and exclusion of thrombi, an effective anticoagulation was initiated and patients underwent EPS within 24 h.

RESULTS

We performed 202 EPSs (radiofrequency catheter ablation, n = 122; overdrive stimulation, n = 64; electrical cardioversion, n = 16) in 139 consecutive patients with AFl. Fifteen patients with a thrombogenic milieu were identified. All of them had paroxysmal atrial fibrillation (AF). Transesophageal echocardiography revealed LA thrombi in two cases (1%). After EPS no thromboembolic complications were observed. Diabetes mellitus, arterial hypertension and a decreased left ventricular ejection fraction were found to be independent risk factors associated with a thrombogenic milieu.

CONCLUSIONS

The findings of a low prevalence of LA appendage thrombi (1%) in patients with AFl and a close correlation between a history of previous embolism and paroxysmal AF support the current guidelines that patients with pure AFl do not require anticoagulation therapy, whereas patients with AFl and paroxysmal AF should receive anticoagulation therapy. In addition, the presence of clinical risk factors should alert the physician to an increased likelihood for a thrombogenic milieu.

Abbreviations and Acronyms
  AFl = atrial flutter
  AF = atrial fibrillation
  DC = direct current
  ECG = electrocardiogram
  EPS = electrophysiologic study
  INR = International Normalized Ratio
  IV = intravenous
  LA = left atrium/atrial
  LVEF = left ventricular ejection fraction
  TEE = transesophageal echocardiography/echocardiographic
  TTE = transthoracic echocardiography/echocardiographic




This article has been cited by other articles:


Home page
HeartHome page
P. Kanagaratnam
Stroke risk in the elderly: it's not all about visible clot
Heart, September 1, 2008; 94(9): 1109 - 1110.
[Full Text] [PDF]


Home page
ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 546S - 592S.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J. J. Blanc, J. Almendral, M. Brignole, M. Fatemi, K. Gjesdal, E. Gonzalez-Torrecilla, P. Kulakowski, G. Y.H. Lip, D. Shah, C. Wolpert, et al.
Consensus document on antithrombotic therapy in the setting of electrophysiological procedures
Europace, May 1, 2008; 10(5): 513 - 527.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D J H McCabe and R D Rakhit
Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke
J. Neurol. Neurosurg. Psychiatry, January 1, 2007; 78(1): 14 - 24.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. D. Demir, M. Soylu, O. Ozdemir, S. Topaloglu, D. Aras, A. Iasmaz, and I. Korkmaz
Do Different Atrial Flutter Types Carry the Same Thromboembolic Risk?
Angiology, September 1, 2005; 56(5): 593 - 599.
[Abstract] [PDF]


Home page
EuropaceHome page
M. F. Scholten, A. S. Thornton, J. M. Mekel, P. J. Koudstaal, and L. J. Jordaens
Anticoagulation in atrial fibrillation and flutter
Europace, January 1, 2005; 7(5): 492 - 499.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 429S - 456S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. Sakurai, T. Hirai, K. Nakagawa, T. Kameyama, T. Nozawa, H. Asanoi, and H. Inoue
Left Atrial Appendage Function and Abnormal Hypercoagulability in Patients With Atrial Flutter
Chest, November 1, 2003; 124(5): 1670 - 1674.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. B. Sparks and J. M. Kalman
Is atrial flutter a risk factor for stroke?
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 785 - 788.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2001 by the American College of Cardiology Foundation.